IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
-12.36%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(-16%)
Cap. Flow
-$5.88M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
99.7%
Holding
12
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Glaukos
GKOS
|
$210K |
| 2 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$68.2K |
Top Sells
| 1 |
HIND
Vyome Holdings, Inc. Common Stock
HIND
|
$6.16M |
Sector Composition
| 1 | Consumer Discretionary | 57.52% |
| 2 | Healthcare | 42.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
The RealReal
REAL
$879M
| $150M | 57.52% | 6,704,080 | – | – |
|
|
AVDR
2
DELISTED
Avedro, Inc Common Stock
AVDR
| $62.3M | 23.91% | 2,745,244 +3,005 | +0.1% | +$68.2K |
|
3
MacroGenics
MGNX
$112M
| $13.7M | 5.26% | 1,074,316 | – | – |
|
4
Neuronetics
STIM
$220M
| $8.57M | 3.29% | 1,030,689 | – | – |
|
|
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $7.84M | 3.01% | 764,918 | – | – |
|
|
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.06M | 2.32% | 1,455,904 | – | – |
|
7
KalVista Pharmaceuticals
KALV
$678M
| $4.51M | 1.73% | 388,766 | – | – |
|
8
Venus Concept
VERO
$4.11M
| $3.48M | 1.34% | 5,355,786 | – | – |
|
9
Cidara Therapeutics
CDTX
$1.66B
| $2.71M | 1.04% | 1,356,813 | – | – |
|
|
HIND
10
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $738K | 0.28% | 380,224 -3,172,015 | -89% | -$6.16M |
|
|
11
Glaukos
GKOS
$5.5B
| $709K | 0.27% | 11,351 +3,356 | +42% | +$210K |
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $75K | 0.03% | 8,293 | – | – |
|